Chronic Disease Management System

描述（由申请人提供）：我们的STTR第二期提案旨在开发和测试Cielo New Vision，这是我们第一期工作设想的可扩展的商业健康信息系统。随着我们完成第一阶段的工作，卫生信息技术（HIT）一直处于国家政策考虑的前沿，第二阶段STTR的建议受到第一阶段研究结果和当前卫生政策背景的影响。我们坚信，现在是启动第二阶段的最佳时机。《美国复苏和再投资法案》（ARRA）包含了鼓励医疗服务提供者促进HIT采用的条款。一个响应我们第一阶段研究结果并允许提供者有资格获得ARRA奖励的系统，将把产品推向市场，满足许多初级保健提供者的需求。我们的第一阶段工作坚定地表明，尽管Cielo诊所存在重大缺陷，限制了它的广泛使用，但它的数据原则允许记录和跟踪从最早的症状表现到诊断和纵向治疗的护理要素，非常适合建立一流的、有针对性的初级保健健康信息解决方案。基于这种数据模型构建的EHR-M或临床群件解决方案允许在一段时间内对患者进行数据跟踪和显示，并根据问题或诊断在患者之间进行数据跟踪和显示。Cielo New Vision的核心是一个基于护理的数据结构，其组件可插入以提供特定功能。实践可以利用核心数据库和任何或所有插件，并连接到他们现有的系统。在这个第二期计划中，我们将根据以下目标开发和测试Cielo New Vision：从临床医生、办公室工作人员和患者那里获得关于纸上原型的反馈，包括当前和潜在用户的反馈。2. 开发建议系统的工作原型。3. 可用性测试和完善工作原型与选定的临床医生和工作人员从当前和未来的实践和患者4。进行一项前瞻性试验，比较Cielo New Vision和EHR实践的关键结果：提供循证服务，满足ARRA有意义使用标准和满足PCMH标准。在第二阶段完成后，我们将提供一个针对初级保健的套件，旨在捕获和报告综合护理和患者的长期需求。该套件在解决已知和预期标准的同时，还将允许现有系统的实践插入其现有技术，利用我们的创新数据模型利用其投资。患者在实践中使用我们的系统将能够跟踪他们的护理和需求，从早期的症状表现到诊断和治疗。

DESCRIPTION (provided by applicant): Our STTR Phase II proposal is designed to develop and test Cielo New Vision, the scalable, commercial health information system envisioned as a result of our Phase I work. Health Information Technology (HIT) has been at the forefront of the nation's policy considerations as we have been completing our Phase I work and this proposal for a Phase II STTR is influenced by both our Phase I findings and the current health policy context. We firmly believe there could be no better time to be launching our Phase II. The American Recovery and Reinvestment Act (ARRA) contains provisions for incentives to medical care providers to foster HIT adoption. A system that responds to our Phase I findings and allows providers to qualify for ARRA incentives, will bring a product to market that will meet the needs of many primary care providers. Our Phase I work firmly establishes that while Cielo Clinic has significant deficiencies limiting its broad use, its data principles which permit recording and tracking of care elements from earliest expression of symptoms through diagnosis and longitudinal treatment are admirably suited to building a first rate, primary care targeted, health information solution. An EHR-M or clinical groupware solution built on such a data model permits data tracking and display within patients over time and across patients by problem or diagnosis. Cielo New Vision will deliver at its core an episode of care based data structure with components that plug in to deliver specific functions. Practices may utilize the core database with any or all of the plug-ins and connect to their existing systems. In this Phase II proposal we will develop and test Cielo New Vision according to the following aims: 1. Elicit feedback from clinicians, office staff and patients on the paper prototype, both from current and prospective users. 2. Develop a working prototype of the proposed system. 3. Usability test and refine the working prototype with selected clinicians and staff from current and prospective practices and patients 4. Conduct a prospective trial comparing Cielo New Vision and EHR practices on key outcomes: delivery of evidence-based services, satisfaction of ARRA meaningful use standards and satisfaction of PCMH standards. At the completion of Phase II we will deliver a primary care targeted suite designed to capture and report comprehensive care and patient needs over time. This suite while addressing known and anticipated standards, will also permit practices with existing systems to plug in their existing technologies, leveraging their investments using our innovative data model. Patients in practices using our system will be able to track their care and needs from the early expression of symptoms through diagnosis and treatment over time. PUBLIC HEALTH RELEVANCE: At the completion of Phase II we will deliver a primary care targeted suite designed to capture and report comprehensive care and patient needs over time. This suite while addressing known and anticipated standards, will also permit practices with existing systems to plug in their existing technologies, leveraging their investments using our innovative data model. Patients in practices using our system will be able to track their care and needs from the early expression of symptoms through diagnosis and treatment over time.